Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04154462 · ClinicalTrials.gov registry record · NA
Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics
A NA study of Medical Scribes, sponsored by VA Boston Healthcare System.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 12
- Study locations
NCT04154462 is a NA study of Medical Scribes that has completed, run by VA Boston Healthcare System. The registered enrollment target is 12 participants. The trial reports 12 study locations across 11 states.
The verdict
NCT04154462, a NA study of Medical Scribes, has completed, sponsored by VA Boston Healthcare System.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 12
- Study locations
Study Summary
Background and study aims: Medical scribes are trained paraprofessionals that assist providers with documenting patient encounters. Prior evidence suggests that scribes may be effective in increasing provider productivity and satisfaction, and decreasing provider time spent on documentation without negatively affecting patient satisfaction. Section 507 of the MISSION Act of 2018 mandated a two-year pilot of medical scribes, which will begin in March 2020 in specialty clinics and emergency departments (EDs) of twelve VA Medical Centers (VAMCs) across the country. The aims of this study are to understand how the introduction of scribes and scribe training affect provider efficiency, patient and provider satisfaction, wait times, and daily patient volume in the VA context. Who can participate? Urban and rural VAMCs willing to be assigned medical scribes for use in EDs or selected high wait time specialty clinics (cardiology, orthopedics). What does the study involve? Four medical scribes will be assigned to each of the 12 VAMC sites randomized into treatment with the VA hiring half as new employees and contracting out for the remaining half. 30% of the scribes will be assigned to emergency departments and the other 70% will be assigned to specialty care. Remaining sites that expressed interest in the pilot but were not randomized treatment will be used as comparators. Provider productivity, patient volume, wait times, and patient satisfaction from the treated sites will be compared to baseline (pre-scribe) data as well as data from comparison sites. What are the possible benefits and risks of participating? VAMCs where medical scribes are introduced may see gains in provider efficiency, reduced wait times, and increased patient satisfaction due to the shifting of administrative burdens associated with documenting patient encounters in electronic health records from providers to these trained professionals. The introduction of medical scribes could complicate patient
Conditions Studied
Interventions
- OTHER Scribes
Study Locations (12)
Texas
- Audie L. Murphy VA Hospital - San Antonio
- Olin E. Teague Veterans' Medical Center - Temple
Arizona
- Southern Arizona VA Health Care System - Tucson
Kentucky
- Robley Rex VA Medical Center - Louisville
Maine
- Togus VA Medical Center - Augusta
Montana
- Fort Harrison VA Medical Center - Helena
New Hampshire
- Manchester VA Medical Center - Manchester
New Jersey
- East Orange VA Medical Center - East Orange
North Dakota
- Fargo VA Medical Center - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-03-01 |
| Est. Completion | 2022-07-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04154462
The ClinicalTrials.gov registry entry for NCT04154462 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Boston Healthcare System, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Medical Scribes appearing as the primary indexed condition, and to 1 intervention - of which Scribes is the first listed.
NCT04154462 reports 12 study locations spanning 11 distinct geographic areas - top geographies include Texas, Arizona, Kentucky.
Frequently Asked Questions
What is clinical trial NCT04154462 about?
NCT04154462 is a clinical study titled "Evaluation of the Use of Medical Scribes in VAMC Emergency Departments and Specialty Care Clinics". Background and study aims: Medical scribes are trained paraprofessionals that assist providers with documenting patient encounters. Prior evidence suggests that scribes may be effective in increasing provider productivity and satisfaction, and decreasing provider time spent on documentation without ...
What is the current status of trial NCT04154462?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2019-03-01. Estimated completion is 2022-07-01.
What conditions does trial NCT04154462 study?
This clinical trial studies the following conditions: Medical Scribes.
What interventions are being tested in trial NCT04154462?
The interventions under investigation include: Scribes (OTHER).
Who is sponsoring clinical trial NCT04154462?
This trial is sponsored by VA Boston Healthcare System, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04154462 being conducted?
This trial has 12 study locations across Arizona, Kentucky, Maine, Montana, New Hampshire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.